Schonfeld Strategic Advisors’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
RCMNY
ACM
PAI
Schonfeld Strategic Advisors's PRTA Position: Q2 2026 in Review
Schonfeld Strategic Advisors increased its Prothena Corp (PRTA) stake by 306% in Q2 2026, buying an estimated $375K and bringing the position to 50,350 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.
Schonfeld Strategic Advisors first reported a position in PRTA in Q3 2021 and has held it in 8 quarters since. The position peaked at $2.72M in Q3 2022. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.
- Schonfeld Strategic Advisors held 50,350 shares of Prothena Corp worth $493K as of Q2 2026.
- Schonfeld Strategic Advisors bought 37,951 Prothena Corp shares in Q2 2026, an estimated $375K.
- Prothena Corp made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1823 holding.
- Schonfeld Strategic Advisors first reported a position in Prothena Corp in Q3 2021 and has held it in 8 quarters since.
- Schonfeld Strategic Advisors's Prothena Corp position peaked at $2.72M in Q3 2022.
- 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.